Cash flows from operating activities: | |
Net income | 1.05B |
Less: Income (loss) from discontinued operations | -1M |
Income from continuing operations | 1.05B |
Adjustments to reconcile to net cash provided by operating activities: | |
Depreciation, decommissioning and amortization | |
Regulatory impacts of net nuclear decommissioning trust earnings (reflected in accumulated depreciation) | |
Other amortization | |
Stock-based compensation | |
Equity in income from unconsolidated affiliates - net | |
Distributions from unconsolidated entities | |
Deferred income taxes and investment tax credits | 127M |
Proceeds from U.S. treasury grants | |
Income from leveraged leases | |
Changes in operating assets and liabilities: | |
Receivables | -235M |
Inventory | -43M |
Margin and collateral deposits - net of collateral received | |
Prepaid taxes | |
Other current assets | |
Rent payments in excess of levelized rent expense | |
Accounts payable | 151M |
Accrued taxes | |
Other current liabilities | -68M |
Derivative assets and liabilities - net | 15M |
Regulatory assets and liabilities - net | |
Other assets | |
Other liabilities | |
Operating cash flows from discontinued operations | |
Net cash provided by operating activities | 2.5B |
Cash flows from financing activities: | |
Long-term debt issued | 397M |
Long-term debt issuance costs | |
Long-term debt repaid | -83M |
Bonds purchased | |
Preference stock issued - net | 294M |
Short-term debt financing - net | 60M |
Settlements of stock-based compensation - net | |
Dividends and distributions to noncontrolling interests | -98M |
Dividends paid | -469M |
Net cash provided by financing activities | -100M |
Cash flows from investing activities: | |
Capital expenditures | -2.77B |
Purchase of interest in acquired companies | |
Proceeds from sale of nuclear decommissioning trust investments | 2.08B |
Purchases of nuclear decommissioning trust investments and other | -1.92B |
Proceeds from partnerships and unconsolidated subsidiaries, net of investment | |
Investments in other assets | |
Effect of consolidation and deconsolidation of variable interest entities | |
Net cash used by investing activities | -2.48B |
Net decrease in cash and cash equivalents | -77M |
Cash and cash equivalents, beginning of period | 161M |
Cash and cash equivalents, end of period | 84M |